MedPath

Quadratus Lumborum Block Versus Fascia Iliaca Block for Hip Arthroplasty

Not Applicable
Conditions
Post Operative Pain
Interventions
Procedure: quadratus lumborum block; (Anterior QLB or QLB III)
Procedure: suprainguinal fascia iliaca block
Procedure: Subarachnoid block
Registration Number
NCT04005326
Lead Sponsor
Bassant M. Abdelhamid
Brief Summary

Quadratus lumborum block is a newly developed block with good performance in lower abdominal surgery. In a cadaveric study, the spread of local anesthetic in the anterior approach of QL block (QL3) was reported to cover nerve roots from T10 to L3. Thus, it was hypothesized that this approach could be used in hip surgeries with minimal motor affection.

This study aims to compare QL3 block and suprainguinal Fascia Iliaca block in the duration of postoperative analgesia, pain scores, motor power in quadriceps muscle, and side effects.

Detailed Description

A randomized, controlled, double blinded, trial will be conducted in Cairo university hospital. Written informed consent will be obtained from all participants. Randomization will be achieved using a computer-generated sequence. Concealment will be achieved using opaque envelopes. Patients scheduled for hip replacement surgeries under subarachnoid block (SAB). e.g. hip hemiarthroplasty, total hip arthroplasty.

On arrival of the patients to regional anesthesia room, patients will be secured with 18-gauge intravenous cannula, and will receive ondansetron (4 mg), and dexamethasone (8 mg IV). Monitoring will include Electrocardiography, non-invasive arterial blood pressure, and pulse oximetry.

Before receiving subarachinoid block, patients will be randomly assigned into one of the two study groups:

QLB Group (n=17): this group will receive ultrasound-guided transmuscular quadratus lumborum block; (Anterior QLB or QLB III) FIB Group (n=17): this group will receive suprainguinal fascia iliaca block To achieve double blinding, patients will receive the block with 30 mL bupivacaine (0.25%) by the anesthetist. Another doctor not involved in the block procedure will evaluate the patients postoperative.

After finishing the block \& assessment of motor power of quadriceps femoris muscle , patient will receive midazolam (2mg intravenous), and then transferred to operation room.

Postoperatively, all patients will receive 1 g paracetamol every 6 hours and 30 mg ketorolac every 12 hours.

If the visual analogue scale (VAS) is 4 or more, a 2 mg morphine increment will be added per time to maintain a resting VAS at \<3 with maximum total 24-hours morphine 10 mg.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Patients scheduled for hip replacement surgeries under subarachnoid block (SAB). e.g. hip hemiarthroplasty, total hip arthroplasty.
Exclusion Criteria
  • Coagulopathy, infection at the injection site,.
  • Allergy to local anesthetics.
  • Severe cardiopulmonary disease (≥ASA IV),.
  • Diabetic or other neuropathies.
  • Patients receiving opioids for chronic analgesic therapy.
  • Contraindication to spinal anesthesia.
  • Inability to comprehend visual analogue scale (VAS).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
QLB Groupquadratus lumborum block; (Anterior QLB or QLB III)this group will receive ultrasound-guided transmuscular quadratus lumborum block; (Anterior QLB or QLB III)
QLB GroupSubarachnoid blockthis group will receive ultrasound-guided transmuscular quadratus lumborum block; (Anterior QLB or QLB III)
FIB Groupsuprainguinal fascia iliaca blockthis group will receive suprainguinal fascia iliaca block
FIB GroupSubarachnoid blockthis group will receive suprainguinal fascia iliaca block
Primary Outcome Measures
NameTimeMethod
Duration of analgesia24 hours postoperative

If the visual analogue scale (VAS) is 4 or more, a 2 mg morphine increment will be added per time to maintain a resting VAS at \<3 with maximum total 24-hours morphine 10 mg.

Secondary Outcome Measures
NameTimeMethod
Onset of sensory block of quadratus lumborum block and fascia iliaca block30 minutes

the time interval between the injection of the study medication till complete loss of sensation

Time to first postoperative analgesic request24 hours postoperative

morphine increment will be added per time to maintain a resting VAS at \<3 with maximum

Total morphine requirements24 hours postoperative

If the visual analogue scale (VAS) is 4 or more, a 2 mg morphine increment will be added per time to maintain a resting VAS at \<3 with maximum total 24-hours morphine 10 mg.

Assessment of the quadriceps muscle power.24 hours

the patient will be in supine position and the patient's knee will be fully flexed, and the patient will be asked to extend it. The motor block is classified as follows: grade 0; normal muscle power, grade I; motor weakness, grade II; complete motor paralysis

Time needed to perform the block30 minutes

the total time of the procedure (quadratus lumborum block or fascia iliaca block) started from patient positioning till completion of local anesthesia injection.

incidence of pain during positioning for spinal block30 minutes

to assess the ability of either two types of the the blocks to relieve pain during positioning for spinal anesthesia

Static visual analogue pain scale24 hours postoperative

Visual analogue pain scale (VAS) at rest. The pain visual analogue pain scale( VAS) is a continuous scale 10 centimeters (100 mm) in length. The scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 \[100-mm scale\]).

Dynamic visual analogue pain scale24 hours postoperative

Visual analogue pain scale (VAS) on movement. The pain visual analogue pain scale( VAS) is a continuous scale 10 centimeters (100 mm) in length. The scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 \[100-mm scale\]).

Trial Locations

Locations (1)

Anesthesia Department

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath